Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
Dangote favours Mombasa over Tanzania's Tanga for Sh2tr oil refinery
Pipeline politics: Why East Africa's joint refinery dream faces slippery path
Debt burden: Inside Treasury's plan to trap Kenya with billions in hidden debt
State plans major audit shakeup to stem graft, wastage of funds
Creative economy key to job creation, says PS Fikirini Jacobs
Beyond the Silicon Savannah: Why Africa's AI revolution must start 'mashinani'
Airtel takes on Safaricom with Sh5.6b data centre
Lokichar-Lamu crude pipeline plan still on, says Treasury
Employers warn of rising costs, urge Ruto to protect jobs
British Airways parent says Mideast war to hit annual profits